Performance funds/ETFs
Growth in fund currency
Available documents (NL)
Available documents (EN)
Available documents for this product 
Quote
Quote
€5,08
Quote date
18-05-2026
Performance in EUR
Date
18-05-2026
This year
0,79%
1 week
0,04%
1 month
0,17%
3 months
0,46%
6 months
1,03%
1 year
2,26%
3 years (annualised)
-
5 years (annualised)
-
Since start (annualised)
3,84%
Indicators
Standard deviation (3yr)
-
Share ratio (3yr)
-
Beta (3yr)
-
Alpha (3yr)
-
Tracking error (3yr)
-
Top 10 holdings (30-04-2026)
France (Republic Of) 0%
7,48 %
Goldman Sachs Group, Inc. 1.625%
0,85 %
Wells Fargo & Co. 1.375%
0,84 %
Takeda Pharmaceutical Co Ltd. 2.25%
0,71 %
JPMorgan Chase & Co. 1.5%
0,70 %
Morgan Stanley 1.375%
0,70 %
Sanofi SA 1.75%
0,68 %
AT&T Inc 1.8%
0,67 %
Apple Inc. 1.625%
0,66 %
Bayer Capital Corporation B.V. 1.5%
0,64 %
Fees
Entry fee
-->Tarievenkaart / Cost information sheet
Exit charges
-->Tarievenkaart / Cost information sheet
Estimated ongoing charges
0,12%
Dividend
Dividend paying
Yes
Dividend
€0,04
Ex-dividend date
19-03-2026
Payment date
-
Dividend frequency
Quarterly
Characteristic
Asset Manager
iShares
Asset class
Bonds
Investment category
Bonds - Europe Corporate Bonds
Active/Passive
Passive
Fund code
212039
Fund code fractional orders
-
Fund manager name
Not available
ISIN
IE000SIZJ2B2
Sustainable Classification
Art. 8, ESG integration
Sustainability Rating
Domicile
Ireland
Currency
EUR
Fund size (mio)
1.260,48 (18-05-2026)
Cut-off time
-
Execution date
-
Inception date
10-08-2023
Benchmark
Bloomberg MSCI D 2026 M € C ESG S GR EUR
Minimum investment amount
-
Assortiment
Self Directed Investing Basic, Self Directed Investing Plus, Investment advice